Article
Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
Human mutation - 1 Apr 2004
Ries-Levavi Liat, Ish-Shalom Tsofia, Frydman Moshe, Lev Dorit, Cohen Shirley, Barkai Gad, Goldman Boleslaw, Byers Peter, Friedman Eitan
Abstract excerpt
Osteogenesis imperfecta (OI) is clinically characterized by abnormal bone fragility, with most patients harboring heterozygote germline mutations in the COL1A1 or COL1A2 genes that encode the chains of type I procollagen, the major protein in bone. More than 250 mutations in both genes in OI pati...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
